Diaceutics, the intelligence and engagement company unlocking the full potential of diagnostic-driven therapies, has released new research revealing a critical shift in precision medicine. Despite ...
Laurel Loomis Rimon examines the new rules recently issued by the Financial Crimes Enforcement Network aimed at countering ...
CertiK's State of Digital Asset Regulations report finds AML penalties topped $900M in H1 2025, eclipsing securities cases as ...
With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...
Tia Stokes is raising her kids without cell phones, though she still posts about them on their respective social media ...
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
PureTech Health plc ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced positive topline ...
Multidisciplinary guidelines suggest using venetoclax-based combination regimens instead of monotherapies for the management of acute myeloid leukemia in older adults. The American Society of ...
SEATTLE, WA / ACCESS Newswire / March 10, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ...
Red nodules on the lower legs can sometimes be an early sign of acute myeloid leukemia (AML). AML is a cancer of the blood and bone marrow that is more common in adults over age 55. While AML is a ...
Relapsed/refractory acute myeloid leukemia (R/R AML) carries a poor prognosis. We report three patients with R/R AML, each of whom had relapsed after at least two prior chemotherapy regimens or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results